Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

38.18 -0.33 (-0.86%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
39 40 Next >
GSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Active Lupus Nephritis
From GSK plc
Via Business Wire
IDEAYA's Cancer Candidate Shows Early Tumor Modulation
Via Benzinga
The 3 Best Market Sectors for the Second Half of 2022
Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into. 
Via InvestorPlace
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Drug Behemoth GSK Delivers Strong Beat And Raise, But Shares Fell
The company expects full-year sales to grow 6%-8% and for earnings to rise 1%. 
Via Investor's Business Daily
New GSK Q2 Highlights: Shingles Vaccine Back In Demand, Antibiotics Recover, Forecast Boost
Via Benzinga
Codexis Shares Slide On CEO Transition
Via Benzinga
Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Blackstone Inc. (NYSE: BX) over Apollo Global Management Inc (NYSE: APO). 
Via Benzinga
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
Reuters Monkeypox Emergency Could Last Months, According To Experts 
Via Benzinga
7 Dividend Stocks to Buy on the Dip
The stock market is volatile and bottoming, making it a good time to buy dividend stocks on the dip. Here are seven worth your consideration. 
Via InvestorPlace
This Analyst Says GSK Spin-Off Haleon Offers "Best Of Both Consumer Worlds"
Citi group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc (NYSE: HLN) with a Buy rating and a price target of 360p. 
Via Benzinga
GSK Completes Spin Off Of Its Consumer Healthcare Business
Via Benzinga
GSK Shares Encouraging Data From Chronic Hepatitis B Candidate
Via Benzinga
3 Biotech Stocks to Buy on the Dip
Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip. 
Via InvestorPlace
Benzinga Before The Bell: Musk's Twitter Lawsuit, Uber Penalized For Overcharging People With Disabilities, Johnson & Johnson Cuts Outlook And Other Top Financial Stories Tuesday, July 19
CNBC Amazon Courts More Trouble As Regulators Inspect Its Warehouses 
Via Benzinga
Post Mega London Stock Exchange Listing, GSK Spinoff Haleon's Plunge Brings Valuation Concerns To The Fore
After GSK (NYSE: GSK) spun off its consumer health division Haleon Plc (LSE: HLN) into a separate entity, shares of the newly listed firm plunged during intraday trade, closing over 6.5% down at... 
Via Benzinga
Air Pollution is a Global Heart and Lung Health Concern
Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by... 
Via FinancialNewsMedia
Topics Climate Change Emissions Energy
Benzinga Before The Bell: Amazon Wages Price War On Tesco, Biden's Campaign Promise To Free Cannabis Prisoners, H&M Exits Russia And Other Top Financial Stories Monday, July 18
Reuters GSK Completes Spin-Off Of Its Consumer Healthcare Business 
Via Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
Via Benzinga
Science Wednesday: Where To See Comet K2 As It Passes The Earth
Five years ago, astronomers were electrified to confirm the discovery of Comet C/2017 K2, more commonly known as Comet K2. At the time, it was believed to be one of the largest comets zooming across... 
Via Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses
From GSK plc
Via Business Wire
7 Retirement Stocks to Buy in July
Planning for retirement can feel overwhelming in bear markets, but these seven retirement stocks can provide a boost to savings. Caterpillar (CAT): The 
Via InvestorPlace
GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community
From GSK plc
Via Business Wire
Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
With Zero Revenue, Laekna Plays Chicken-And-Egg Game With Investors
Key Takeaways: Laekna is seeking a Hong Kong IPO to raise funds to accelerate the commercialize two core products licensed from Novartis The company currently is not generating... 
Via Benzinga
Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes
The companies' shot was more than 93% effective in previously infected people. 
Via Investor's Business Daily
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.